GlassScriptPhysician profile
Douglas C Barnas
NPI 1396066288
$956.79
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $338.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.90 | 2019-2020 | |
| Minerva Surgical, INC | $313.74 | 2020 | |
| Lsi Solutions INC | $83.97 | 2019 | |
| Merck Sharp & Dohme LLC | $48.68 | 2019 | |
| Therapeuticsmd, INC. | $32.53 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.06 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.54 | 2019 | |
| Pfizer INC. | $11.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Barnas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.